血液系统恶性肿瘤患者的惰性感染:波士顿在细胞毒性治疗前筛查结核病和类圆线虫病的单中心经验
Indolent infections in patients with hematologic malignancy: A single-center experience screening for tuberculosis and strongyloidiasis prior to cytotoxic therapy in Boston.
作者信息
Reifler K A, Francoeur Smith T, Bodanapu G, Fagan M, Bourque D L, Sloan J M
机构信息
Section of Infectious Diseases, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Department of Internal Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
出版信息
Leuk Res Rep. 2024 Nov 22;22:100489. doi: 10.1016/j.lrr.2024.100489. eCollection 2024.
Individuals with hematologic malignancy have increased risk of latent tuberculosis infection (LTBI) reactivation and (SS) dissemination. However, screening prior to chemotherapy or corticosteroids is not routine. We conducted a LTBI and SS screening intervention amongst patients with hematologic malignancies. Over one-third immigrated from countries with high TB incidence and SS prevalence, and some had additional risk factors (HIV, HTLV-1, eosinophilia). The intervention increased screening rates but universal screening was not achieved. Screening positivity was similar pre- and post-intervention. We demonstrate a population with increased indolent infection reactivation risk. Specific infectious screening guidelines are needed to prevent significant morbidity.
血液系统恶性肿瘤患者发生潜伏性结核感染(LTBI)再激活和粟粒性播散(SS)的风险增加。然而,化疗或使用糖皮质激素前的筛查并非常规操作。我们对血液系统恶性肿瘤患者进行了LTBI和SS筛查干预。超过三分之一的患者来自结核病发病率和SS患病率高的国家,部分患者还有其他危险因素(HIV、HTLV-1、嗜酸性粒细胞增多)。该干预提高了筛查率,但未实现普遍筛查。干预前后筛查阳性率相似。我们证明了一个惰性感染再激活风险增加的人群。需要特定的感染筛查指南以预防严重发病情况。
相似文献
本文引用的文献
Mediterr J Hematol Infect Dis. 2024-7-1
Clin Microbiol Rev. 2023-12-20
MMWR Morb Mortal Wkly Rep. 2022-3-25
Int J Infect Dis. 2020-11
Pathogens. 2020-6-13